Italia markets closed

Dow Jones
38.358,14
-328,18(-0,85%)
Nasdaq
16.724,88
-10,13(-0,06%)
Nikkei 225
38.923,03
+435,13(+1,13%)
EUR/USD
1,0891
+0,0037(+0,34%)
Bitcoin EUR
63.482,67
+1.089,61(+1,75%)
CMC Crypto 200
1.442,80
-25,14(-1,71%)

NVCR Jan 2026 22.500 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

8,00

0,00

(0,00%)

In data: 03:59PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in